Research

Vanderbilt University Medical Center (VUMC) has received an $11 million program project renewal grant from the National Heart, Lung and Blood Institute to study the genetics and underlying biological mechanisms that lead to idiopathic pulmonary fibrosis (IPF). Read More

Vanderbilt University researchers from diverse scientific disciplines are joining forces to help crack the stubborn mysteries of addiction through the new Vanderbilt Center for Addiction Research. Read More

Research in the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) aimed at developing innovative new treatments for schizophrenia just received a powerful assist from The William K. Warren Foundation. Read More

A peptide molecule relaxes airway smooth muscle and may be a potential therapeutic for asthma that has become resistant to standard therapies. Read More

U.S. Representative Jim Cooper honored nuclear physicists Joe Hamilton and A.V. Ramayya Aug. 12 for their role in the discovery of the new superheavy element 117 that has been provisionally named Tennessine. Read More

Greg Walker has been selected to be a fellow of the American Society of Mechanical Engineers for “exceptional engineering achievements and contributions to the engineering profession.” Read More

Eight entering engineering graduate students have received research fellowships from the National Science Foundation, as did two Vanderbilt engineering undergraduate students who are pursuing their graduate studies elsewhere. Read More

Vanderbilt researchers have discovered that regulation of cell volume plays a role in nerve degeneration and peripheral neuropathies. Read More

Michelle Reising Scobey, assistant professor of the practice and co-director of the M.Ed. clinical psychological assessment program at Peabody College, has been given an Emerging Leader award by the Nashville Area Chamber of Commerce and the Young Professionals Network of Nashville. Read More

The National Institutes of Health (NIH) has awarded a major renewal grant to continue the National Research Resource for Imaging Mass Spectrometry at Vanderbilt University School of Medicine. Read More

Increasing expression of a transcription factor called KLF2 can promote immunological self-tolerance and “tune down” autoimmunity, researchers at Vanderbilt University Medical Center reported recently. Read More

Using an antibody generated at Vanderbilt University Medical Center that neutralizes the Ebola virus, researchers at the Scripps Research Institute in La Jolla, California, have determined the structure of a “decoy” protein that may enable the virus to evade detection by the immune system. Read More

Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression. Read More

Hypoxia (lack of enough oxygen) is bad for the body as a whole, but in the neighborhood where infection-fighting antibodies arise, may be important for keeping proper order. Read More

Terunaga Nakagawa, with colleagues from Japan and Oxford University in England, has discovered the bridgelike molecular structure of a mysterious glutamate receptor. Read More

Research by Associate Professor of Psychology Suzana Herculano-Houzel finds that human intelligence comes from the number of neurons in our brains—and it was the invention of cooking that made neuron development possible. Read More

Renowned experts across disciplines will speak on Judaeo-Arabic history and culture at an international conference at Vanderbilt University Aug. 15-18. Read More

Researchers from Vanderbilt University have developed porous polymer-fiber electrodes that may make fuel cells more powerful. Read More

Tuberculosis (TB) remains an important public health problem, particularly among people infected with the human immunodeficiency virus (HIV). Read More

The Robert J. Kleberg Jr. and Helen C. Kleberg Foundation has awarded a $3 million grant to Vanderbilt-Ingram Cancer Center (VICC) investigators in support of VICC’s drug discovery program. The gift awarded over the next three years from the private, San Antonio, Texas-based foundation will enable VICC researchers to pursue the development of new compounds to block the activity of cancer-causing genes and proteins that had previously been considered “undruggable.” Read More